Primary malignant pericardial mesothelioma presenting with cardiac tamponade.

Cardiac tamponade Primary malignant pericardial mesothelioma Surgical intervention

Journal

International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872

Informations de publication

Date de publication:
2020
Historique:
received: 26 05 2020
revised: 14 07 2020
accepted: 14 07 2020
pubmed: 28 7 2020
medline: 28 7 2020
entrez: 28 7 2020
Statut: ppublish

Résumé

Primary malignant pericardial mesothelioma is a rare tumor that is very difficult to diagnose. Furthermore, it is a lethal disease, because patients usually have progressed at the time of referral. We report a 44-year-old man with primary malignant pericardial mesothelioma. He was referred to our hospital for the diagnosis and treatment of a massive pericardial effusion and huge tumor. Pericardiocentesis was performed, but we could not obtain definitive diagnosis, and the cardiac tamponade continued along with the signs/symptoms. He required surgical intervention for the diagnosis and treatment. After surgery, his signs/symptoms improved. He received adjuvant therapy, although he died 7 months after surgery. Primary malignant pericardial mesothelioma is a rare tumor. The most common signs and symptoms are related to constriction of the heart by the tumor and/or effusion. Even if the pericardial fluid specimen obtained by pericardiocentesis is negative for malignant cells, primary malignant pericardial mesothelioma should be included in the differential diagnosis. Because the malignancy is usually advanced at the time of diagnosis, it has been difficult to cure. Radiation and chemotherapy have been used in addition to surgery, but have been minimally effective. The outcome of our patient with pericardial malignant mesothelioma was dismal. The indications for surgical intervention should be carefully considered except for critical cases requiring alleviation of immediate life-threating conditions.

Identifiants

pubmed: 32717680
pii: S2210-2612(20)30565-4
doi: 10.1016/j.ijscr.2020.07.054
pmc: PMC7385038
pii:
doi:

Types de publication

Case Reports

Langues

eng

Pagination

253-256

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Gen Thorac Cardiovasc Surg. 2018 May;66(5):257-262
pubmed: 29594875
J Thorac Dis. 2014 Dec;6(12):E272-5
pubmed: 25590007
Ann Thorac Surg. 2013 Aug;96(2):680-1
pubmed: 23353042
Tex Heart Inst J. 1994;21(2):170-4
pubmed: 8061543
Case Rep Oncol. 2009 Jul 29;2(2):125-132
pubmed: 20740175
Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):396-8
pubmed: 19131929
Heart. 2004 Jan;90(1):e4
pubmed: 14676267
Jpn Circ J. 2000 May;64(5):385-8
pubmed: 10834456
Onco Targets Ther. 2017 Jun 19;10:3049-3057
pubmed: 28790839
Clin Lung Cancer. 2019 Mar;20(2):e152-e157
pubmed: 30594459
J Thorac Oncol. 2016 Feb;11(2):142-54
pubmed: 26811225
Int J Surg. 2018 Dec;60:132-136
pubmed: 30342279

Auteurs

Shigefumi Matsuyama (S)

Department of Cardiovascular Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan; Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan. Electronic address: shimatsuyama@gmail.com.

Tomohiro Imazuru (T)

Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Masateru Uchiyama (M)

Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Hiroo Ota (H)

Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Mitsuru Iida (M)

Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Tomoki Shimokawa (T)

Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Classifications MeSH